info flag

 

COVID-19 Update >

 

Proven to slow kidney function decline in adults who are at risk for rapidly progressing ADPKD

Getting Ahead of ADPKD, Video Thumbnail
Getting Ahead of ADPKD, Video Thumbnail

Cari is living with rapidly progressing autosomal dominant polycystic kidney disease, or ADPKD, and taking JYNARQUE® (tolvaptan).

At the age of 10, diagnostic imaging confirmed Cari’s parent’s fears: she, like her father, had autosomal dominant polycystic kidney disease (ADPKD). As little could be done for a young patient with no symptoms, her parents made the difficult choice to wait to share the diagnosis with Cari until she was an adult and better able to process the information. Growing up, Cari watched her father deal with his own ADPKD symptoms, dialysis, and treatment, so the significance of an ADPKD diagnosis was not lost on her. Cari knows her parents’ hope was to protect her, but as an adult, she is now very open about ADPKD, advocates for others with the condition, and spreads awareness in hopes of helping everyone in the ADPKD community.

Please remember that none of the information discussed in this article should replace the conversations with your healthcare provider. Cari is sharing her own thoughts and experiences, so please keep that in mind as your thoughts and experiences may be different. 

Talk to your doctor to see if JYNARQUE is right for you.

What was it like to learn not only that you had ADPKD, but that you’d been diagnosed with it for years?

Cari: It’s a lot to process, even when you have no symptoms. I didn’t know then, but my daily life wouldn’t be affected by ADPKD symptoms for at least 10 more years. At that time, not disclosing information on any chronic diseases you might have could preclude you from employment or private health or life insurance. Thankfully, there is now legislation that protects against discrimination of pre-existing conditions.

However, there’s something frightening that my generation of patients has in common: we are not strangers to ADPKD. Many of us watched our parents deal with a brutal disease daily, where the only strategy was to wait until your kidneys failed, then start dialysis or be fortunate enough to get a transplant. Receiving a diagnosis of an unknown illness is scary, but the fear that comes with a diagnosis of something that’s already impacted your family life is something else entirely.

What did living with ADPKD look like for your dad? It sounds like he went through a lot.

Cari: It’s hard to remember a time when ADPKD wasn’t a big part of my day-to-day life. When I was eight years old, my dad started receiving hemodialysis at home—something unheard of in the mid-1980s—and it allowed him to keep working full time to provide for our family. Dialysis is hard on the body, though. Even when we were young, we knew dad needed a lot of rest, and there were days where he was very sick. He was fortunate to receive a kidney that was a near-perfect match just two years after beginning dialysis. While that freed him from the hemodialysis machine, the numerous medications caused issues of their own, including those designed to prevent transplant rejection. Over the next 30 years, he had sepsis five times and three different types of cancer, and we were acutely aware of how tenuous his health was.

Cari wanted to take charge of her health

“I wanted to…set the best example possible for my girls by taking charge of my health, being open to research, and sharing my story with others.”

I’m sure seeing everything your parents went through affected your own approach to ADPKD.

Cari: Through all of this, my dad kept a positive attitude about the many health challenges he faced. He was respected by his doctors for how well he understood his conditions and medications. If he felt a medication wasn’t working for him, he’d speak up. He wasn’t afraid to ask questions, even if it was about a course of action they were recommending. Through his example, I learned the value of being my own best advocate and playing an active role in my care.

Was there a moment that the importance of managing your own ADPKD hit home for you?

Cari: Personally, becoming a mom brought my ADPKD into focus. I’ve had three complicated and high-risk pregnancies, but other than that, I’m fortunate that I’ve lived relatively symptom-free until the last 10 years or so. And because ADPKD can impact families through generations, I knew something of the guilt my dad experienced. I wanted to channel all of those emotions into something positive and set the best example possible for my girls by taking charge of my health, being open to research, and sharing my story with others.

Cari is living with ADPKD

“I find both relief and purpose in being open about living with ADPKD and all that goes along with it.”

When did you realize you needed to move beyond managing ADPKD on your own?

Cari: Like many ADPKD patients, the first symptom I needed to treat was my high blood pressure. It’s scary because this and other kidney diseases can move silently in your body. I was 30 before I realized that silent progression was happening to me, and I knew from my upbringing that I needed to be more proactive than reactive. I started making healthier life choices right away in conjunction with finding the right medication to control my blood pressure, and I was amazed at how quickly I started to feel better. A few years later when planning my third pregnancy, I researched alternative ways to slow the progression of ADPKD online and discovered a clinical trial for an investigational drug called tolvaptan, later approved by the FDA to treat adults with rapidly progressing ADPKD as JYNARQUE. I began taking the trial medication in January 2016.

In 2018, I transitioned from the trial to the commercially available medication. I applied for the Otsuka Patient Support Program, which helped tremendously. I also learned that the Patient Support Program can, if eligible, cover the bloodwork required by the JYNARQUE REMS program that I need to be part of to monitor my liver function. JYNARQUE can cause serious and potentially fatal liver problems, so I stick to my scheduled checkups to ensure my liver is working properly.

Being on JYNARQUE, I drink much more water than I ever did before, but over time, I’ve grown accustomed to it and found that the search for new and flavorful ways to consume water and keep track of my intake is now part of my daily routine. Of course, this is my experience, and everyone is different.

You are fairly active in the ADPKD community, correct?

Cari: Through my research on potential treatments and my quest to make some sense out of having a chronic illness, I’ve been blessed to find initiatives ranging from grassroots political advocacy to patient advisory boards focused on bringing the patient community together via technology. In addition to feeling like I’m using my disease as a positive platform, I’ve met some amazing people who truly understand me because they face the same health challenges.

Why is raising awareness of ADPKD so important to you?

Cari: Part of being open about my health journey is honoring my dad’s memory and legacy. In one generation, we’ve moved from guarding information about our health out of fear of discrimination to openly sharing our diagnosis in hope that a fellow patient will identify with us and find encouragement. I find both relief and purpose in being open about living with ADPKD and all that goes along with it. The people in my life who know about my condition understand and support me! My hope is that through my commitment to awareness of chronic kidney diseases, others will take active roles in their health journeys through early detection of ADPKD, healthy living, and becoming a strong voice for themselves and others.

JYNARQUE Interstitial

Are you starting or currently taking JYNARQUE but can't make it to your required labwork?

We will come to you.

Learn more

 

JYNARQUE Interstitial modal

X

To help, we are offering a Home Collection Service available to all current, eligible patients taking JYNARQUE. A phlebotomist will be sent to your home to collect a blood sample for your REMS*-required blood work. The collection and processing will be free of charge to you.

 

If you are interested in this service, please reach out to your prescribing physician directly to get more details on this program or contact the Otsuka Patient Support Center at 1-855-242-7787 who are available from 9AM to 5PM EST.

*Risk Evaluation and Mitigation Strategy

Learn more

ISI Block Title

IMPORTANT SAFETY INFORMATION and INDICATION for JYNARQUE® (tolvaptan)

  • Serious liver problems. JYNARQUE can cause serious liver problems that can lead to the need for a liver transplant or can lead to death. Stop taking JYNARQUE and call your healthcare provider right away if you get any of the following symptoms:
    • feeling tired
    • loss of appetite
    • nausea
    • right upper stomach (abdomen) pain or tenderness
    • vomiting
    • fever
    • rash
    • itching
    • yellowing of the skin and white part of the eye (jaundice)
    • dark urine

It is important that you have a blood test before you start JYNARQUE to help reduce your risk of liver problems. Your healthcare provider will do a blood test to check your liver:

  • before you start taking JYNARQUE
  • at 2 weeks and 4 weeks after you start treatment with JYNARQUE
  • then monthly for 18 months during treatment with JYNARQUE
  • and every 3 months from then on

Because of the risk of serious liver problems, JYNARQUE is only available through a restricted distribution program called the JYNARQUE Risk Evaluation and Mitigation Strategy (REMS) Program.

Do not take JYNARQUE if you:

  • have a history of liver problems or have signs or symptoms of liver problems, excluding polycystic liver disease
  • cannot feel if you are thirsty or cannot replace fluids by drinking
  • have been told that the amount of sodium (salt) in your blood is too high or too low
  • are dehydrated
  • are allergic to tolvaptan or any of the ingredients in JYNARQUE
  • are unable to urinate

Tell your healthcare provider about all your medical conditions, including if you:

  • have a history of sodium (salt) levels that are too low
  • are pregnant or plan to become pregnant. It is not known if tolvaptan will harm your unborn baby. Tell your healthcare provider if you become pregnant or think that you may be pregnant
  • are breastfeeding or plan to breastfeed. It is not known if tolvaptan passes into your breast milk. Do not breastfeed during your treatment with JYNARQUE. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

  • Taking JYNARQUE with certain medicines could cause you to have too much tolvaptan in your blood. JYNARQUE should not be taken with certain medications. Your healthcare provider can tell you if it is safe to take JYNARQUE with other medicines
  • Do not start taking a new medicine without talking to your healthcare provider

JYNARQUE may cause serious side effects, including:

  • Too much sodium in your blood (hypernatremia) and loss of too much body fluid (dehydration). In some cases, dehydration can lead to extreme loss of body fluid called hypovolemia. You should drink water when you are thirsty and throughout the day and night. Stop taking JYNARQUE and call your healthcare provider if you cannot drink enough water for any reason, such as not having access to water, or vomiting or diarrhea. Tell your healthcare provider if you get any of the following symptoms:
    • dizziness
    • fainting
    • weight loss
    • a change in the way your heart beats
    • feeling confused or weak

What should you avoid while taking JYNARQUE?

Do not drink grapefruit juice during treatment with JYNARQUE. This could cause you to have too much tolvaptan in your blood.

The most common side effects of JYNARQUE are:

  • thirst and increased fluid intake
  • making large amounts of urine, urinating often, and urinating at night

These are not all the possible side effects of JYNARQUE. Talk to your healthcare provider about any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.

If you have any questions about your health or medicines, talk to your healthcare professional.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1‑800‑438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

INDICATION:

What is JYNARQUE?

JYNARQUE is a prescription medicine used to slow kidney function decline in adults who are at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). It is not known if JYNARQUE is safe and effective in children.

Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.

COVID-19 UPDATE

With the COVID-19 situation constantly developing, your health is our top priority. We hope that you and your families are staying safe and healthy during this unprecedented time.

If you are currently taking JYNARQUE® (tolvaptan), we encourage you to stay in close contact with your healthcare professional team regarding regular appointments and treatment management plans.

At this time, there is no expected impact on medication supply.

During the current COVID-19 pandemic, the JYNARQUE® (tolvaptan) REMS Program requirements remain in effect, as the health of patients who use this product is our top priority. Ongoing blood monitoring required by the REMS Program is extremely important due to the potential risk of serious liver injury from treatment with JYNARQUE. For these lab requirements during COVID-19 pandemic, we are able to temporarily offer our Mobile Phlebotomy Collection Service at no-cost for all patients taking JYNARQUE who prefer to have the REMS required blood work collected at home.

In helping patients who have lost a job or health insurance coverage due to the COVID-19 pandemic and to get through these challenging times, we have extended our Patient Support Program to provide ‘no-cost’ access for patients in the U.S. who are taking JYNARQUE. Please call Otsuka Patient Support at 1-855-242-7787 for more information on both programs.

For help accessing JYNARQUE, go to www.otsukapatientsupport.com/jynarque or call Otsuka Patient Support at 1-855-242-7787. The nurses at Otsuka Patient Support can answer questions related to Product Accessibility, Reimbursement and connecting patients to local treatment sites in their community.

Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.

September 202010US20EBC0103

IMPORTANT SAFETY INFORMATION and INDICATION for JYNARQUE® (tolvaptan)
ISI Block Title

IMPORTANT SAFETY INFORMATION and INDICATION for JYNARQUE® (tolvaptan)

  • Serious liver problems. JYNARQUE can cause serious liver problems that can lead to the need for a liver transplant or can lead to death. Stop taking JYNARQUE and call your healthcare provider right away if you get any of the following symptoms:
    • feeling tired
    • loss of appetite
    • nausea
    • right upper stomach (abdomen) pain or tenderness
    • vomiting
    • fever
    • rash
    • itching
    • yellowing of the skin and white part of the eye (jaundice)
    • dark urine

It is important that you have a blood test before you start JYNARQUE to help reduce your risk of liver problems. Your healthcare provider will do a blood test to check your liver:

  • before you start taking JYNARQUE
  • at 2 weeks and 4 weeks after you start treatment with JYNARQUE
  • then monthly for 18 months during treatment with JYNARQUE
  • and every 3 months from then on

Because of the risk of serious liver problems, JYNARQUE is only available through a restricted distribution program called the JYNARQUE Risk Evaluation and Mitigation Strategy (REMS) Program.

Do not take JYNARQUE if you:

  • have a history of liver problems or have signs or symptoms of liver problems, excluding polycystic liver disease
  • cannot feel if you are thirsty or cannot replace fluids by drinking
  • have been told that the amount of sodium (salt) in your blood is too high or too low
  • are dehydrated
  • are allergic to tolvaptan or any of the ingredients in JYNARQUE
  • are unable to urinate

Tell your healthcare provider about all your medical conditions, including if you:

  • have a history of sodium (salt) levels that are too low
  • are pregnant or plan to become pregnant. It is not known if tolvaptan will harm your unborn baby. Tell your healthcare provider if you become pregnant or think that you may be pregnant
  • are breastfeeding or plan to breastfeed. It is not known if tolvaptan passes into your breast milk. Do not breastfeed during your treatment with JYNARQUE. Talk to your healthcare provider about the best way to feed your baby during this time

Tell your healthcare provider about all the medicines you take, including prescription medicines, over-the-counter medicines, vitamins, and herbal supplements.

  • Taking JYNARQUE with certain medicines could cause you to have too much tolvaptan in your blood. JYNARQUE should not be taken with certain medications. Your healthcare provider can tell you if it is safe to take JYNARQUE with other medicines
  • Do not start taking a new medicine without talking to your healthcare provider

JYNARQUE may cause serious side effects, including:

  • Too much sodium in your blood (hypernatremia) and loss of too much body fluid (dehydration). In some cases, dehydration can lead to extreme loss of body fluid called hypovolemia. You should drink water when you are thirsty and throughout the day and night. Stop taking JYNARQUE and call your healthcare provider if you cannot drink enough water for any reason, such as not having access to water, or vomiting or diarrhea. Tell your healthcare provider if you get any of the following symptoms:
    • dizziness
    • fainting
    • weight loss
    • a change in the way your heart beats
    • feeling confused or weak

What should you avoid while taking JYNARQUE?

Do not drink grapefruit juice during treatment with JYNARQUE. This could cause you to have too much tolvaptan in your blood.

The most common side effects of JYNARQUE are:

  • thirst and increased fluid intake
  • making large amounts of urine, urinating often, and urinating at night

These are not all the possible side effects of JYNARQUE. Talk to your healthcare provider about any side effect that bothers you or that does not go away. For more information, ask your healthcare provider or pharmacist.

If you have any questions about your health or medicines, talk to your healthcare professional.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at 1‑800‑438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

INDICATION:

What is JYNARQUE?

JYNARQUE is a prescription medicine used to slow kidney function decline in adults who are at risk for rapidly progressing autosomal dominant polycystic kidney disease (ADPKD). It is not known if JYNARQUE is safe and effective in children.

Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE.